Guidance for clinical trials for children and adolescents with chronic hepatitis C.
about
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysisIs liver biopsy still needed in children with chronic viral hepatitis?Pegylated interferon alfa and ribavirin for children with chronic hepatitis CTreatment of children with chronic viral hepatitis: what is available and what is in store.Treatment of chronic viral hepatitis C in children and adolescents: UK experience.Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children.Natural history and response to treatment of HCV infection among Egyptian survivors of childhood malignancy.Vertical genotype 1 HCV infection treated successfully in the second year of life: a case report.Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children.Progression of liver diseasesAssociation of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C.Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.Current treatment options and response rates in children with chronic hepatitis C.Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.
P2860
Q28281519-63A346C2-50C0-4FBA-B5E2-DE2A47B98732Q30398796-1C01FFEB-4AD9-4F28-80AA-39787FABA348Q36637715-5DC496C8-7AB5-48BF-8F6C-62AFC54411C8Q38127616-C36EA3E8-4A40-4AAB-8974-EF3FDA116365Q38184887-CC9B972D-40E3-403D-A0FE-91D8694C9856Q38234869-C10B854D-3448-4D8F-B71B-A345CBFB76B0Q38989158-AB4C043B-2156-4797-8098-21AF814963ABQ40265125-2DA6D2CF-7256-41A5-B742-7B115F616505Q41535163-6E0E5350-4A85-44CC-8632-320C14736C55Q42263132-7567B70D-E157-404D-8768-9B9C9FB26982Q42284820-86AA7276-A802-4BED-BE08-F4BE4B1934B8Q43040672-A644EC5C-3A3F-4146-A8A3-DD2B914C2296Q43046510-41482749-7AC4-448C-A418-A2B50E973A40Q50553046-B72B0FD3-1594-415A-A101-43119B8818F6
P2860
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@nl
type
label
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@nl
prefLabel
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@nl
P2093
P50
P1476
Guidance for clinical trials for children and adolescents with chronic hepatitis C.
@en
P2093
Agnès Saint Raymond
Deirdre Kelly
Florence Lacaille
Giorgina Mieli-Vergani
Jan Taminiau
Sophie Olivier
Stefan Wirth
P304
P356
10.1097/MPG.0B013E3181F6F09C
P407
P577
2011-02-01T00:00:00Z